Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03456973 · ClinicalTrials.gov registry record · NA
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03456973: Completed NA study, sponsored by Milton S. Hershey Medical Center.
NCT03456973 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03456973, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The investigators propose to build and test a supportive care software platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) to be provided to metastatic breast cancer patients on Android Tablets. This program will be tested in 50 metastatic breast cancer patients within the Penn State Cancer Institute's 28 county catchment area. The company with whom the investigator will partner to develop this application is already working with multiple investigators at the institution (Webster Group).
Primary Outcome
The proportion of women who consent, take a tablet home, who actually interact with the tablet and participate at least one month of the program.
Interventions
- BEHAVIORAL Nurse AMIE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
What the finished NCT03456973 record still lists
NCT03456973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Nurse AMIE is the first listed.
NCT03456973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03456973 about?
NCT03456973 is a clinical study titled "Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer". The investigators propose to build and test a supportive care software platform called Nurse AMIE (Addressing Metastatic Individuals Everyday) to be provided to metastatic breast cancer patients on Android Tablets. This program will be tested in 50 metastatic breast cancer patients within the Penn S...
What is the current status of trial NCT03456973?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-10-01. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT03456973?
The interventions under investigation include: Nurse AMIE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03456973?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03456973's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI